Why BioNTech Thrashed the Market on Thursday
Top coronavirus stock BioNTech (NASDAQ: BNTX) was also tops with investors on Thursday. The Germany-based biotech's shares trounced the S&P 500 by closing the day more than 4% higher, thanks to some positive -- if expected -- news on the regulatory front.
Comirnaty, the coronavirus vaccine developed by BioNTech in partnership with U.S. pharmaceutical sector giant Pfizer (NYSE: PFE), was granted Emergency Use Authorization as a booster by the Food and Drug Administration Wednesday night.
Image source: Getty Images.
Source Fool.com